Markers such as serum levels of CD163 (sCD163), the presence of CD68+ or CD163+ CD204+ macrophages in the tumor region can be used as indicator of macrophage or TAM activation following drug treatment [35]. The gene discussed is CD163; the disease is neoplasm.